CoChat

Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up

Open access
Stepankova, Lenka, Kralikova, Eva, Zvolska, Kamila, Pankova, Alexandra, Ovesna, Petra, Blaha, Milan, Brose, Leonie S · 2017 · Annals of Behavioral Medicine

The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index; 14 of the 28 sources its claims cite were checked for support.

Abstract

Smoking is more prevalent among people with depression. Depression may make cessation more difficult and cessation may affect depression symptoms. The aims of this study were to assess the associations between (1) baseline depression and 1-year smoking abstinence and (2) abstinence and change in depression. Observational study using data collected routinely in a smoking cessation clinic in the Czech Republic from 2008 to 2014. Aim 1: N = 3775 patients; 14.3% reported mild and 15.4% moderate/severe baseline depression levels measured using Beck's Depression Inventory (BDI-II). Logistic regressions assessed if depression level predicted 1-year biochemically verified abstinence while adjusting for patient and treatment characteristics. Aim 2: N = 835 patients abstinent at 1 year; change in depression was analysed using Chi-square statistics, t test and mixed method analyses of variance. Rate of abstinence was lower for patients with mild (32.5%, OR = 0.68; 95% CI: 0.54 to 0.87, p = 0.002) and moderate/severe depression (25.8%; OR = 0.57, 95% CI: 0.45 to 0.74, p < 0.001) compared with patients without depression (40.5%). Across abstinent patients, the majority with baseline depression reported lower depression levels at follow-up. Overall mean (SD) BDI-II scores improved from 9.2 (8.6) to 5.3 (6.1); t(834) = 14.6, p < 0.001. There were significant main effects of time (F(1832) = 880.8, p < 0.001, partial η2 = 0.51) and baseline depression level (F(2832) = 666.4, p < 0.001, partial η2 = 0.62) on follow-up depression and a significant depression * time interaction (F(2832) = 296.5, p < 0.001, partial η2 = 0.42). In this effective smoking cessation clinic, depression at the start of treatment predicted reduced smoking abstinence 1 year later. Patients abstinent from smoking experienced considerable improvement in depression.

Overview

CoChat Summary

TL;DR

In a Czech smoking cessation clinic, baseline depression predicted lower 1-year biochemically verified abstinence, and patients abstinent at 1 year showed substantial improvement in depression. The observational design could not compare depression change in those who continued smoking.

Key findings

  • Overall CO-verified 1-year abstinence was 37.1%. Compared with no/minimal depression (40.5% abstinent), mild baseline depression was associated with lower abstinence (32.5%; adjusted OR = 0.68, 95% CI 0.54–0.87, p = 0.002) and moderate/severe depression with lower abstinence (25.8%; adjusted OR = 0.57, 95% CI 0.45–0.74, p < 0.001).
  • Among 835 abstinent patients with baseline and follow-up BDI-II, mean (SD) depression improved from 9.2 (8.6) to 5.3 (6.1); t(834) = 14.6, p < 0.001. Mixed-model ANOVA showed main effects of time (F(1,832) = 880.8, p < 0.001, partial η² = 0.51), baseline depression level (F(2,832) = 666.4, p < 0.001, partial η² = 0.62), and depression × time interaction (F(2,832) = 296.5, p < 0.001, partial η² = 0.42).
  • Median BDI-II decreased from 5 to 3 for no/minimal, 16 to 7 for mild, and 25 to 10 for moderate/severe baseline depression (all p < 0.001). Baseline antidepressant use was marginally associated with lower abstinence (32.9% vs 37.7%; OR = 0.81, 95% CI 0.65–0.999, p = 0.049; adjusted OR = 0.79, 95% CI 0.62–1.01, p = 0.061).
  • Number of visits was a strong predictor: in the primary model, 5 or more visits had OR = 9.57 (95% CI 7.59–12.08, p < 0.001) versus fewer than 3; in the model including length of pharmacotherapy, OR = 5.91 (95% CI 4.47–7.83, p < 0.001).

Methods

  • Observational study using routinely collected data from the Center for Tobacco Dependence, General University Hospital, Prague, Czech Republic, 2008–2014. Treatment was face-to-face counselling plus a choice of pharmacotherapy; it did not include specific treatment for depression or other mental health problems.
  • Aim 1: logistic regressions of 1-year biochemically verified abstinence (Russell Standard: self-reported ≤5 cigarettes since quit date and exhaled CO <10 ppm; lost to follow-up counted as not abstinent) on baseline BDI-II category (none/minimal ≤13, mild 14–19, moderate/severe ≥20), adjusted for age, gender, education, marital status, FTND dependence, other mental health problems, number of visits, and pharmacotherapy type. Primary model N = 3380 (abstract states N = 3775); additional model including length of pharmacotherapy N = 2545.
  • Aim 2: among patients abstinent at 1 year with baseline and follow-up BDI-II (N = 835), change in depression was analysed with chi-square statistics, paired t test, and mixed-model ANOVA; also examined by baseline depression level and pharmacotherapy.

Limitations

  • The paper states: all patients were outpatients, potentially limiting generalisability to patients ill enough to be hospitalised; depression at follow-up was generally not recorded for non-abstainers, so changes could not be compared between abstinent and non-abstinent patients; only two time points were available, so the direction of the association cannot be determined.
  • The paper states/acknowledges: observational routine-clinic data with no randomised control group; other mental health problems were self-reported and combined because frequencies were low; reverse causality for visit attendance is possible, since successful patients may be more likely to attend subsequent visits.
  • Evident from the text: the abstract reports N = 3775 for Aim 1 while the methods and Table 1 report N = 3380, and this discrepancy is not explained; counting lost-to-follow-up patients as not abstinent may bias abstinence rates downward.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s12160-016-9869-6

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Change in level of depression from baseline to 1-year follow-up among those abstinent at follow-up (N = 835)
Fig. 1 Change in level of depression from baseline to 1-year follow-up among those abstinent at follow-up (N = 835)CC BY · PubMed Central
Fig. 2 Mean (95%CI) depression (BDI-II) score at baseline and follow-up by baseline level of depression among those abstinent at follow-up (N = 835)
Fig. 2 Mean (95%CI) depression (BDI-II) score at baseline and follow-up by baseline level of depression among those abstinent at follow-up (N = 835)CC BY · PubMed Central
Fig. 3 Mean (95%CI) depression (BDI-II) score at baseline and follow-up by pharmacotherapy among those abstinent at follow-up (N = 835)
Fig. 3 Mean (95%CI) depression (BDI-II) score at baseline and follow-up by pharmacotherapy among those abstinent at follow-up (N = 835)CC BY · PubMed Central

Verification

Claims the paper makes

10 Valid · 1 Not valid · 7 Not checked · 43 Own results and interpretations

31 more claims · 4 with their cited sources checked

Create a free account to see all 61 claims and to verify the 14 references still open.

See all claims — free account
  • Probably not a substantial claim. 14
  • It may state two separate claims as one. 13

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Statistics recomputed

Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.

  • Consistentt(834) = 14.6reported p < .001 · recomputed p < .001

    “t(834) = 14.6, p < .001”

  • Consistentz = -14.1reported p < .001 · recomputed p < .001

    “Z = −14.1, p < .001”

  • Consistentz = -12.9reported p < .001 · recomputed p < .001

    “Z = −12.9, p < .001”

  • ConsistentF(1, 832) = 880.8reported p < .001 · recomputed p < .001

    “F(1, 832) = 880.8, p < .001”

  • ConsistentF(2, 832) = 666.4reported p < .001 · recomputed p < .001

    “F(2, 832) = 666.4, p < .001”

5 of 7 · the rest aren’t loaded

2 more recomputed tests

Create a free account to see every test the Stats check recomputed.

See all tests — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 39 references

Research works printed but not linked: 3

  1. Royal College of Physicians, Royal College of Psychiatrists: smoking and mental health. London: RCP, 2013.
  2. Fiore MC, Jaen CR, Baker TBea: treating tobacco use and dependence: 2008 update. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service, 2008.
  3. Cooper J, Borland R, Yong HH, Fotuhi O: The impact of quitting smoking on depressive symptoms: Findings from the International Tobacco Control Four-Country Survey. Addiction. 2016; 111(8):1448-1456. doi: 10.1111/add.13367 . · DOI · Paper page

Cited by

See all 78

Metadata

Authors
Stepankova, L., Kralikova, E., Zvolska, K., Pankova, A., Ovesna, P., Blaha, M., & Brose, L. S.
Affiliations
  • Masaryk University (CZ)
  • King's College London (GB)
Corresponding author
Brose, Leonie S
Venue
Annals of Behavioral Medicine
Published
2016-12-29
Volume
51
Issue
3
Pages
454-463
ISSN
  • 0742-5554 (ISSN-L)
  • 0883-6612
  • 1532-4796
OpenAlex
W2563836337
Cited by
78
References
40
Citations by year
2026: 3 · 2025: 7 · 2024: 6 · 2023: 9 · 2022: 10 · 2021: 11 · 2020: 11 · 2019: 10 · 2018: 7 · 2017: 4
FWCI
5.59
Type
journal article
Language
en
Open access
Locations
  • Annals of Behavioral Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion, cc-by)
Funders
  • Cancer Research UK (C52999/A19748)
  • Univerzita Karlova (Prvouk P25/LF1/2)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords
depression, smoking cessation, smoking abstinence, depression severity, smoking cessation clinics, Beck Depression Inventory-II, follow-up outcomes, tobacco dependence treatment, smoking cessation pharmacotherapy, smoking cessation self-help
MeSH terms
Adult, Counseling, Depression, Female, Humans, Male, Middle Aged, Recurrence, Smoking, Cohort Studies, Smoking Cessation, Treatment Outcome, Evidence-Based Practice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up. https://app.cochat.ai/papers/10.1007/s12160-016-9869-6
The paper
Stepankova, L., Kralikova, E., Zvolska, K., Pankova, A., Ovesna, P., Blaha, M., & Brose, L. S. (2017). Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up. Annals of Behavioral Medicine. https://doi.org/10.1007/s12160-016-9869-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.